📢EMA's human medicines committee, the #CHMP, recommends 1⃣1⃣ new #medicines for approval in the 🇪🇺
Among these:
☑️4 #cancer treatments
☑️A #diabetes medicine
☑️A medicine for #asthma
☑️A treatment for #lupus
#PublicHealth 🧵 https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-18-21-july-2022
RT @ECDC_EU: How to address the challenges surrounding access to #HealthData throughout the EU? What is needed in this matter to open up new perspectives for research and innovation?
We are taking part in a pilot project for the European Health Data Space to find out: https://www.ecdc.europa.eu/en/news-events/ecdc-participate-pilot-project-european-health-data-space-health-research-europe
RT @ECDC_Outbreaks: #UPDATE:
#ECDC/@WHO_Europe #monkeypox surveillance bulletin.
10604 cases of #mpx identified through IHR mechanisms & official resources from 36 countries in the European region. Case-based data were reported via #TESSy for 9281 cases from 31 countries.
RT @EFSA_EU: Our awareness campaign #StopASF has been extended for the third consecutive year.
It is run in partnership with local authorities in eighteen countries: 🇦🇱 🇧🇦 🇧🇬 🇭🇷 🇨🇿 🇪🇪 🇬🇷 🇭🇺 🇽🇰 🇱🇻 🇱🇹 🇲🇪 North🇲🇰 🇵🇱 🇷🇴 🇷🇸🇸🇰🇸🇮
👉https://www.efsa.europa.eu/en/news/detect-prevent-report-efsas-african-swine-fever-campaign-extended-third-year
RT @nicogoncas: It was a pleasure for me to visit the @EMA_News yesterday in Amsterdam. We discuss new vaccines, pandemic and new pharmaceutical legislation.
Thank you Emer Cooke and Team. You make Europe stronger.
RT @EU_HaDEA: 🆕Prior Information Notice
A new #EU4Health tender will open soon, focusing on EU's #healthpreparedness and on training programmes for #healthspecialists
Find out more on #HaDEA website⤵️
https://hadea.ec.europa.eu/news/new-prior-information-notice-under-eu4health-2022-07-20_en
RT @EU_HIS_Unit: 📢Very proud to be a partner in the European Health Data Space pilot project for secondary use of #healthdata that will be launched soon!
Our consortium led by @HealthDataHub brings together 16 partners from 10 European countries and organisations. #EHDS
👉https://www.health-data-hub.fr/sites/default/files/2022-07/Press%20release%20-%20EHDS2%20pilot%20launch.pdf
DARWIN EU®, EMA’s network of data and services in Europe for a better use of #RealWorldEvidence when assessing 💊, will act as a pathfinder for #EHDS.
#DARWINEU will connect to the #EHDS services and support its use in medicines regulation.
RT @HealthDataHub: 🇪🇺 La Commission européenne vient d’annoncer sa décision de choisir le consortium mené par le Health Data Hub pour mettre en place un projet pilote de l’Espace européen des donné…
#Covid19 update:
EMA has started evaluating a request to extend the use of the #COVID19vaccine Comirnaty, in children from 6 months to 4 years.
RT @SKyriakidesEU: ▶️🇪🇺 Scientific Advice Platform discussed the latest on #COVID19 and #Monkeypox.
With #COVID19 numbers rising @ECDC_EU and @EMA_News published recommendations for preparing vaccination campaigns and health systems for the autumn.
We must use this time to get ready.
RT @ECDC_Outbreaks: This document offers an overview of the available scientific and epidemiological evidence and provides public health considerations to support decisions on the implementation of additional booster doses of #COVID19vaccines.
RT @ECDC_Outbreaks: @WHO_Europe This document outlines considerations to support the continuity of national surveillance systems & public health laboratories for surveillance of: #influenza, #SARSCoV2, and potentially other respiratory viruses (e.x. #RSV) in the 2022/2023 winter season and beyond.
RT @EU_Health: Depending on how the situation evolves, additional boosters may be needed for other groups at a later stage➡️this will be driven by science
Remember: measures like frequent hand washing,masks & ventilation also help reduce transmission & protect our communities
#StrongerTogether
RT @EU_Health: #COVID19: What's a vaccine booster?
Boosters are extra vaccine doses that maintain/restore protection against death or hospitalisation from COVID-19
They are important because protection from primary COVID-19 vaccination may reduce over time
RT @ECDC_Outbreaks: #Update:
Joint #ECDC/@WHO_Europe #Monkeypox surveillance bulletin.
8238 cases of #mpx have been identified through IHR mechanisms and official public resources up to 12 July from 35 countries of the European region.
6900 cases were reported in TESSy.
https://monkeypoxreport.ecdc.europa.eu/
RT @ECDC_EU: Things we know about the current #monkeypox outbreak:
1⃣ has a human-to-human transmission,
2⃣ affects mostly male people from 18 to 50 y.o.,
3⃣ causes minor/moderate symptoms (mainly rash).
Find out more on our dedicated website here:
https://www.ecdc.europa.eu/en/monkeypox-outbreak
RT @ECDC_EU: Updated 🚦 maps are online!
These maps aim to support the
@EUCouncil recommendation on travel measures in the EU during #COVID19 pandemic.
Some regions are greyed out due to insufficient testing rate or lack of data.
Color-blind friendly map below.
https://www.ecdc.europa.eu/en/covid-19/situation-updates/weekly-maps-coordinated-restriction-free-movement
RT @eurofound: Unmet mental health care is a growing issue in Europe. This is particularly the case for women, with almost a quarter (24%) reporting unmet mental care needs.
Read the results of our e-survey: https://ow.ly/ItIh50JLJyn
RT @EFSA_EU: #Antibiotics misuse in human and veterinary medicine can lead to #AntimicrobialResistance, which happens when bacteria or viruses develop a resistance to the drugs we use to treat them.
Learn more about #AMR and how it's linked to #FoodSafety.
https://ow.ly/5STi50JPtiK
Unofficial automated mirror. No copyright asserted. ∎ Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.